id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1977-N-0023-0002,FDA,FDA-1977-N-0023,"Internal Memorandum from Valerie J. Miguele (HFD-560) to FDA DDM (HFA-305) June 17, 1996",Other,Memorandum,1996-07-02T04:00:00Z,1996,7,,,2019-02-13T14:22:59Z,,0,0,09000064805da1b5
FDA-1977-N-0023-0001,FDA,FDA-1977-N-0023,"Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Proposed Amendment to the Tentative Final Monograph",Proposed Rule,Notice of Proposed Rulemaking (NPRM),1996-06-25T04:00:00Z,1996,6,1996-06-25T04:00:00Z,1996-09-12T03:59:59Z,2019-03-23T23:59:37Z,96-14894,0,0,09000064805da1b4